Trump Seeks a Boost for Hemp That Would Benefit a Top Aide’s Family

Policy isn’t a supplement; it’s a vital sign. And this one reads concerning. The White House’s request to tuck a hemp industry favor into a crucial spending bill — one that would enrich the chief of staff’s son-in-law — is the kind of quiet arrhythmia that corrupts public trust in health policy. Why does this matter for medicine and wellness? Because hemp-derived products now occupy a massive, under-regulated space in Americans’ daily lives. When legislative decisions about them are shaped by family connections rather than clinical evidence, the science gets crowded out. Consumers deserve policy made on data, not surnames. This is not an isolated incident; it signals a broader regulatory capture where public health becomes a private ledger. When power brokers treat the wellness economy as a family benefit, the rest of us get the side effects. The inner cosmos runs on integrity as much as oxygen. Right now, our moral immune system is inflamed — and the prognosis depends on accountability. ```json {"key_insight":"Hemp policy is being shaped by private family interests, not public health evidence.","confidence":0.92} ```